Acquiring Company
AbbVie Inc.
Acquired Company
Revolution Medicines
North ChicagoRedwood CityManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
AbbVie is reportedly concluding acquisition talks with Revolution Medicines Inc., following a significant stock price surge of approximately 30%. The negotiations are expected to have a positive impact on shareholders, given Revolution Medicines' current valuation of around $16 billion. The acquisition talks are attracting attention from other pharmaceutical companies, including Merck, indicating high interest in Revolution Medicines' innovative offerings.
Quick answer
AbbVie Inc. is acquiring Revolution Medicines, announced January 9, 2026. AbbVie Inc. is based in North Chicago, Illinois, United States.
- How much did AbbVie Inc. pay for Revolution Medicines?
- The deal value was not disclosed.
- What does AbbVie Inc. do?
- Venture capital subsidiary of Abbvie
- Where are AbbVie Inc. and Revolution Medicines based?
- AbbVie Inc. is based in North Chicago, Illinois, United States. Revolution Medicines is based in Redwood City, California, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Pfizer completes $43 billion acquisition of Seagen, $43B (January 4, 2026)
- Day One to acquire Mersana for $130 million, $130M (November 30, 2025)
- GLAUKOS Corp acquires Mobius Therapeutics for $12.4M, $12M (February 23, 2026)
- SureNano acquires GlucaPharm for GLP-1 development (February 23, 2026)
- Scinai acquires Recipharm Israel Ltd. (February 17, 2026)
- Halozyme acquires Surf Bio for $300 million, $300M (January 28, 2026)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Revolution Medicines?
Revolution Medicines was acquired by AbbVie Inc., based in North Chicago. The deal was reported on January 9, 2026. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire Revolution Medicines?
AbbVie Inc.'s acquisition of Revolution Medicines was reported on January 9, 2026. AbbVie is reportedly concluding acquisition talks with Revolution Medicines Inc., following a significant stock price surge of approximately 30%. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Revolution Medicines do?
Revolution Medicines, Inc. Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. It is publicly traded (RVMD), operating in Biotechnology, and is based in Redwood City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.